Company CVAbout Venus Remedies Ltd 
Venus Remedies Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Incorporated in 1989 Venus Remedies Ltd (formerly known Venus Glucose Pvt Ltd), was converted into Public Limited Company in 1994 and then changed into Venus Remedies Limited. The Company was promoted and managed by Chaudhary & Family. The Company is one of the handful player in pharmaceutical sector to launch injectables globally. It has manufacturing facilities in Panchkula and Baddi , and research and development centre under the name of Venus Medicine Research Centre (in India).
Company Coordinates
Company Details
S C No 857 Cabin No 10 2nd Flr, N A C Manimajra Chandigarh Chandigarh ( U T ) : 160101
Registrar Details
Link Intime India Pvt Ltd, A-40, 2nd Floor, Naraina Industrial Area , Phase II, Near Batra Banquet Hall, New Delhi
Capital StructureCapital Structure
Present Equity Capital
INR 13.37 Cr
Number of Shares
1.34 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
31-May-2021
1.34
13.37
1025000
10
Conversion of Warrants
18-Mar-2017
1.23
12.34
900000
10
Conversion of Warrants
18-Mar-2017
1.23
12.34
900000
10
Conversion of Warrants
30-Sep-2013
1.14
11.44
200
10
Unspecified
30-Sep-2013
1.14
11.44
200
10
Unspecified
19-Jun-2013
1.14
11.44
900000
10
Conversion of Warrants
19-Jun-2013
1.14
11.44
900000
10
Conversion of Warrants
30-Mar-2013
1.05
10.54
800000
10
Conversion of Warrants
30-Mar-2013
1.05
10.54
800000
10
Conversion of Warrants
27-Feb-2012
97.42
9.74
600000
10
Conversion of Warrants
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 4 FIIs (1.86%)
Promoter with highest holding
Sunev Pharma Solutions Limited (17.21%)
Highest Public shareholder
K.b.shekar (1.88%)
Individual Investors Holdings
45.3%
Board of Directors
Management
Designation
Remuneration
Pawan Chaudhary
Chairman & Managing Director
1.22 cr
Manu Chaudhary
Joint Managing Director
1.22 cr
Peeyush Jain
Deputy Managing Director
73.93 lacs
Ashutosh Jain
Executive Director
67.69 lacs
Gilbert Wenzel
Independent Director
0
S. K. Chadha
Independent Director
75.0 k
Neha Kodan
Company Sec. & Compli. Officer
0
Navdeep Sud
Independent Director
65.0 k
Savita Gupta
Independent Director
50.0 k
Akshansh Chaudhary
Whole-time Director
40.5 lacs
Nps Monga
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of Stock in Trade
25.0395
0%
Purchase of Stock in Trade
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Sale of Products - Pharmaceutical Goods
350.25
98.64%
Other Operating Revenue
2.96
0.83%
Income from Research Activities
1.86
0.52%
Sale of Products - Pharmaceutical Goods
Sale of Products - Pharmaceutical Goods
Other Operating Revenue
Other Operating Revenue
Income from Research Activities
Income from Research Activities
Stock DNARevenue and Profits:
Net Sales:
193 Cr
(Quarterly Results - Sep 2025)
Net Profit:
20 Cr
Pharmaceuticals & Biotechnology
INR 1,003 Cr (Micro Cap)
16.00
34
0.00%
-0.37
10.52%
1.73
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
